Investigating the recognition of a novel ligand by gamma-delta T cells and the translation of this interaction into molecules for future cancer immunotherapy

Project Information

gdTCR-Ligand

Grant agreement ID: 749010

DOI

10.3030/749010

Project closed

EC signature date 10 May 2017

Start date 1 June 2017

End date 31 May 2019

Funded under

• EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions

Total cost

€ 177 598,80

EU contribution

€ 177 598,80

Coordinated by

UNIVERSITAIR MEDISCH CENTRUM UTRECHT
Netherlands

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Publications

Peer reviewed articles (1)

Identification of a tumor-specific allo-HLA–restricted γδTCR

Author(s): G. J. J. Kierkels, W. Scheper, A. D. Meringa, I. Johanna, D. X. Beringer, A. Janssen, M. Schiffler, T. Aarts-Riemens, L. Kramer, T. Straetemans, S. Heijhuurs, J. H. W. Leusen, E. San José, K. Fuchs, M. Griffioen, J. H. Falkenburg, L. Bongiovanni, A. de Bruin, D. Vargas-Diaz, M. Altelaar, A. J. R. Heck, L. D. Shultz, F. Ishikawa, M. I. Nishimura, Z. Sebestyén, J. Kuball
Published in: Blood Advances, Issue 3/19, 2019, Page(s) 2870-2882, ISSN 2473-9537
Publisher: American Society of Hematology
DOI: 10.1182/bloodadvances.2019032409

Intellectual Property Rights

Patent (2)

BISPECIFIC MOLECULES COMPRISING GAMMA-DELTA TCR AND T-CELL OR NK CELL BINDING DOMAIN

Application/Publication number: WO 2019156566
Date: 2019-02-10
Applicant(s): UNIVERSITAIR MEDISCH CENTRUM UTRECHT

COMPOSITIONS AND METHODS FOR CELL TARGETING THERAPIES

Application/Publication number: WO 2018211115
Date: 2018-05-18
Applicant(s): UNIVERSITAIR MEDISCH CENTRUM UTRECHT